ReP USP - Resultado da busca

Artigo de periodico
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo (2023)
Silvestre, Renata Nacasaki ; Eitler, Jiri; Azevedo, Júlia Teixeira Cottas de ; Tirapelle, Mariane Cariati; Fantacini, Daianne Maciely Carvalho ; Souza, Lucas Eduardo Botelho de ; Swiech, Kamilla ; Covas, Dimas Tadeu ; Calado, Rodrigo Tocantins ; Montero, Paola Ortiz; Malmegrim, Kelen Cristina Ribeiro ; Figueiredo, Marxa L.; Tonn, Torsten; Picanço-Castro, Virgínia
Source: Frontiers in Immunology. Unidades: FMRP, FCFRP
Subjects: ANTÍGENOS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, v. 14, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1226518. Acesso em: 07 nov. 2024.
APA
Silvestre, R. N., Eitler, J., Azevedo, J. T. C. de, Tirapelle, M. C., Fantacini, D. M. C., Souza, L. E. B. de, et al. (2023). Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, 14, 1-15. doi:10.3389/fimmu.2023.1226518
NLM
Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518
Vancouver
Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518
Artigo de periodico
Correction: Lesbon et al. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. Viruses 2021, 13, 2474 (2022)
Lesbon, Jéssika Cristina Chagas ; Poleti, Mirele Daiana ; Oliveira, Elisângela Chicaroni de Mattos ; Patané, José Salvatore Leister; Clemente, Luan Gaspar ; Viala, Vincent Louis; Ribeiro, Gabriela; Giovanetti, Marta; Alcantara, Luiz Carlos Junior de; Teixeira, Olivia ; Nonato, Maria Cristina; Lima, Loyze Paola Oliveira de; Martins, Antonio Jorge; Barros, Claudia Renata dos Santos; Marqueze, Elaine Cristina; Bernardino, Jardelina de Souza Todão; Moretti, Debora Botequio; Brassaloti, Ricardo Augusto; Cassano, Raquel de Lello Rocha Campos; Mariani, Pilar Drummond Sampaio Correa; Slavov, Svetoslav Nanev; Santos, Rafael Bezerra dos; Rodrigues, Evandra Strazza; Santos, Elaine Vieira; Borges, Josiane Serrano; La Roque, Debora Glenda Lima de; Kitajima, Joao Paulo; Santos, Bibiana; Assato, Patricia Akemi; Costa, Felipe Allan da Silva da; Banho, Cecilia Artico; Sacchetto, Livia; Moraes, Marilia Mazzi; Palmieri, Melissa; Silva, Fabiana Erica Vilanova da; Grotto, Rejane Maria Tommasini; Souza-Neto, Jayme A; Nogueira, Mauricio Lacerda; Coutinho, Luiz Lehman ; Calado, Rodrigo Tocantins; Machado Neto, Raul; Covas, Dimas Tadeu; Kashima, Simone; Elias, Maria Carolina; Sampaio, Sandra Coccuzzo; Fukumasu, Heidge
Source: Viruses. Unidades: FZEA, FMRP, ESALQ, CENA, FCFRP
Subjects: COVID-19, GENES, MUTAÇÃO GENÉTICA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LESBON, Jéssika Cristina Chagas et al. Correction: Lesbon et al. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. Viruses 2021, 13, 2474. Viruses, v. 14, p. 1-2, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14091967. Acesso em: 07 nov. 2024.
APA
Lesbon, J. C. C., Poleti, M. D., Oliveira, E. C. de M., Patané, J. S. L., Clemente, L. G., Viala, V. L., et al. (2022). Correction: Lesbon et al. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. Viruses 2021, 13, 2474. Viruses, 14, 1-2. doi:10.3390/v14091967
NLM
Lesbon JCC, Poleti MD, Oliveira EC de M, Patané JSL, Clemente LG, Viala VL, Ribeiro G, Giovanetti M, Alcantara LCJ de, Teixeira O, Nonato MC, Lima LPO de, Martins AJ, Barros CR dos S, Marqueze EC, Bernardino J de ST, Moretti DB, Brassaloti RA, Cassano R de LRC, Mariani PDSC, Slavov SN, Santos RB dos, Rodrigues ES, Santos EV, Borges JS, La Roque DGL de, Kitajima JP, Santos B, Assato PA, Costa FA da S da, Banho CA, Sacchetto L, Moraes MM, Palmieri M, Silva FEV da, Grotto RMT, Souza-Neto JA, Nogueira ML, Coutinho LL, Calado RT, Machado Neto R, Covas DT, Kashima S, Elias MC, Sampaio SC, Fukumasu H. Correction: Lesbon et al. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. Viruses 2021, 13, 2474 [Internet]. Viruses. 2022 ; 14 1-2.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v14091967
Vancouver
Lesbon JCC, Poleti MD, Oliveira EC de M, Patané JSL, Clemente LG, Viala VL, Ribeiro G, Giovanetti M, Alcantara LCJ de, Teixeira O, Nonato MC, Lima LPO de, Martins AJ, Barros CR dos S, Marqueze EC, Bernardino J de ST, Moretti DB, Brassaloti RA, Cassano R de LRC, Mariani PDSC, Slavov SN, Santos RB dos, Rodrigues ES, Santos EV, Borges JS, La Roque DGL de, Kitajima JP, Santos B, Assato PA, Costa FA da S da, Banho CA, Sacchetto L, Moraes MM, Palmieri M, Silva FEV da, Grotto RMT, Souza-Neto JA, Nogueira ML, Coutinho LL, Calado RT, Machado Neto R, Covas DT, Kashima S, Elias MC, Sampaio SC, Fukumasu H. Correction: Lesbon et al. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. Viruses 2021, 13, 2474 [Internet]. Viruses. 2022 ; 14 1-2.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3390/v14091967
Artigo de periodico
Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy (2022)
Gonçalves, Maynara Santana; Silva, Djúlio César Zanin da; Henrique Neto, Álvaro; Moraes, Daniela Aparecida de; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Bragagnollo, Vinícius; Azevedo, Júlia Teixeira Cottas de; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naira Zambelli ; Rodrigues, Maria Carolina de Oliveira
Source: Therapeutic Advances in Musculoskeletal Disease. Unidades: FMRP, FCFRP
Subjects: BIOMARCADORES, CÉLULAS, ENDOTÉLIO, DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maynara Santana et al. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, v. 14, p. 1- 13, 2022Tradução . . Disponível em: https://doi.org/10.1177/1759720X221084845. Acesso em: 07 nov. 2024.
APA
Gonçalves, M. S., Silva, D. C. Z. da, Henrique Neto, Á., Moraes, D. A. de, Vasconcelos, M. Y. K., Lima Júnior, J. R., et al. (2022). Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, 14, 1- 13. doi:10.1177/1759720X221084845
NLM
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1177/1759720X221084845
Vancouver
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1177/1759720X221084845
Artigo de periodico
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients (2022)
Silva, Djúlio César Zanin da; Gonçalves, Maynara Santana; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Moraes, Daniela A.; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naíra Zambelli; Rodrigues, Maria Carolina de Oliveira
Source: Arthritis Research & Therapy. Unidades: FMRP, FCFRP
Subjects: TECIDO CONJUNTIVO, DOENÇA CRÔNICA, DOENÇAS AUTOIMUNES, FIBROBLASTOS, CÉLULAS-TRONCO, MATRIZ EXTRACELULAR, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Djúlio César Zanin da et al. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, v. 24, n. 1, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1186/s13075-022-02779-w. Acesso em: 07 nov. 2024.
APA
Silva, D. C. Z. da, Gonçalves, M. S., Vasconcelos, M. Y. K., Lima Júnior, J. R., Dias, J. B. E., Moraes, D. A., et al. (2022). Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, 24( 1), 1-11. doi:10.1186/s13075-022-02779-w
NLM
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Vancouver
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Subjects: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 07 nov. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Mesenchymal stromal cells in viral infections: implications for COVID-19 (2021)
Rocha, José Lucas Martins; Oliveira, Waldir César Ferreira de; Noronha, Nádia de Cássia ; Santos, Natalia Cristine Dias dos; Covas, Dimas Tadeu; Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Stem Cell Reviews and Reports. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, COVID-19, ADJUVANTES IMUNOLÓGICOS, INSUFICIÊNCIA RESPIRATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, José Lucas Martins et al. Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, v. 17, n. 1, p. 71-93, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-020-10032-7. Acesso em: 07 nov. 2024.
APA
Rocha, J. L. M., Oliveira, W. C. F. de, Noronha, N. de C., Santos, N. C. D. dos, Covas, D. T., Picanço-Castro, V., et al. (2021). Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, 17( 1), 71-93. doi:10.1007/s12015-020-10032-7
NLM
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Vancouver
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 07 nov. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients (2021)
Azevedo, Júlia Teixeira Cottas de ; Costa, Thalita Cristina de Mello; Lima, Keli Cristina de ; Maciel, Thiago Trovati; Palma, Patrícia Vianna Bonini de; Darrigo Júnior, Luiz Guilherme ; Grecco, Carlos Eduardo Setanni; Stracieri, Ana Beatriz Pereira Lima; Elias, Juliana Bernardes; Pieroni, Fabiano; Cunha, Renato Luiz Guerino ; Pinto, Ana Cristina Silva ; Santis, Gil Cunha De ; Covas, Dimas Tadeu ; Hermine, Olivier; Simões, Belinda Pinto ; Oliveira, Maria Carolina; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Frontiers in Immunology. Unidades: FMRP, FCFRP, FM
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, ANEMIA FALCIFORME, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients. Frontiers in Immunology, v. 12, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.774442. Acesso em: 07 nov. 2024.
APA
Azevedo, J. T. C. de, Costa, T. C. de M., Lima, K. C. de, Maciel, T. T., Palma, P. V. B. de, Darrigo Júnior, L. G., et al. (2021). Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients. Frontiers in Immunology, 12, 1-15. doi:10.3389/fimmu.2021.774442
NLM
Azevedo JTC de, Costa TC de M, Lima KC de, Maciel TT, Palma PVB de, Darrigo Júnior LG, Grecco CES, Stracieri ABPL, Elias JB, Pieroni F, Cunha RLG, Pinto ACS, Santis GCD, Covas DT, Hermine O, Simões BP, Oliveira MC, Farias KCRM de. Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.774442
Vancouver
Azevedo JTC de, Costa TC de M, Lima KC de, Maciel TT, Palma PVB de, Darrigo Júnior LG, Grecco CES, Stracieri ABPL, Elias JB, Pieroni F, Cunha RLG, Pinto ACS, Santis GCD, Covas DT, Hermine O, Simões BP, Oliveira MC, Farias KCRM de. Long-term effects of allogeneic hematopoietic stem cell transplantation on systemic inflammation in sickle cell disease patients [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fimmu.2021.774442
Artigo de periodico
Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Berzoti-Coelho, Maria Gabriela ; Pereira, Illy Enne Gomes ; Frantz, Fabiani Gai ; Souto, Elizabeth Xisto; Covas, Dimas Tadeu; Figueiredo-Pontes, Lorena Lobo de; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro ; Castro, Fabíola Attié de
Source: Frontiers in Oncology. Unidades: FCFRP, FMRP
Subjects: NEOVASCULARIZAÇÃO PATOLÓGICA, MEDULA ÓSSEA, CITOCINAS, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 07 nov. 2024.
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Artigo de periodico
Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1 (2021)
Bomfim, Aline de Sousa; Freitas, Marcela Cristina Corrêa de; Castro, Virgínia Picanço e; Soares Neto, Mario Abreu; Pádua, Ricardo; Covas, Dimas Tadeu ; Russo, Elisa Maria de Sousa
Source: Biotechnology Letters. Unidades: FMRP, FCFRP
Subjects: FATORES DE COAGULAÇÃO SANGUÍNEA, HEMOFILIA, LINHAGEM CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOMFIM, Aline de Sousa et al. Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1. Biotechnology Letters, v. 43, n. 1, p. 143-152, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10529-020-03040-7. Acesso em: 07 nov. 2024.
APA
Bomfim, A. de S., Freitas, M. C. C. de, Castro, V. P. e, Soares Neto, M. A., Pádua, R., Covas, D. T., & Russo, E. M. de S. (2021). Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1. Biotechnology Letters, 43( 1), 143-152. doi:10.1007/s10529-020-03040-7
NLM
Bomfim A de S, Freitas MCC de, Castro VP e, Soares Neto MA, Pádua R, Covas DT, Russo EM de S. Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1 [Internet]. Biotechnology Letters. 2021 ; 43( 1): 143-152.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s10529-020-03040-7
Vancouver
Bomfim A de S, Freitas MCC de, Castro VP e, Soares Neto MA, Pádua R, Covas DT, Russo EM de S. Generation of hyperfunctional recombinant human factor IX variants expressed in human cell line SK-Hep-1 [Internet]. Biotechnology Letters. 2021 ; 43( 1): 143-152.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s10529-020-03040-7
Artigo de periodico
Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor (2021)
Noronha, Nadia de Cássia; Mizukami, Amanda; Orellana, Maristela Delgado; Oliveira, Maria Carolina de; Covas, Dimas Tadeu; Swiech, Kamilla; Malmegrim, Kelen Cristina Ribeiro
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ANÓXIA, REATORES BIOQUÍMICOS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nadia de Cássia et al. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, v. 168, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2021.107949. Acesso em: 07 nov. 2024.
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Oliveira, M. C. de, Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2021). Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, 168, 1-11. doi:10.1016/j.bej.2021.107949
NLM
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Artigo de periodico
Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers (2020)
Gonzalez Gil, Liseth Viviana; Singh, Harminder; Silva, Juliana de Sá da; Santos, Diogo Peres dos; Covas, Dimas Tadeu ; Swiech, Kamilla ; Torres Suazo, Claudio Alberto
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ENGENHARIA QUÍMICA, MEDICINA REGENERATIVA, REATORES BIOQUÍMICOS, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZALEZ GIL, Liseth Viviana et al. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, v. 162, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2020.107710. Acesso em: 07 nov. 2024.
APA
Gonzalez Gil, L. V., Singh, H., Silva, J. de S. da, Santos, D. P. dos, Covas, D. T., Swiech, K., & Torres Suazo, C. A. (2020). Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers. Biochemical Engineering Journal, 162, 1-11. doi:10.1016/j.bej.2020.107710
NLM
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Vancouver
Gonzalez Gil LV, Singh H, Silva J de S da, Santos DP dos, Covas DT, Swiech K, Torres Suazo CA. Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers [Internet]. Biochemical Engineering Journal. 2020 ; 162 1-11.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2020.107710
Trabalho de evento-resumo periodico
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
Silvestre, Renata Nacasaki; Eitler, J.; Fantacini, Daianne Maciely Carvalho ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu; Tonn, T.; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 07 nov. 2024. , 2020
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Trabalho de evento-resumo periodico
Optimizing intracellular signaling domains for CAR-NK cells (2020)
Azevedo, Júlia Teixeira Cottas de; Silvestre, Renata Nacasaki; Pessoni, André Moreira ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, NEOPLASIAS, PROLIFERAÇÃO CELULAR, LEUCEMIA, LINFOMA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.710. Acesso em: 07 nov. 2024. , 2020
APA
Azevedo, J. T. C. de, Silvestre, R. N., Pessoni, A. M., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.710
NLM
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Vancouver
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Artigo de periodico
Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems (2020)
Silva, Juliana de Sá da; Severino, Patricia; Wodewotzky, Thaila Isabel; Covas, Dimas Tadeu ; Swiech, Kamilla ; Marti, Luciana Cavalheiro; Suazo, Claudio Alberto Torres
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, REATORES BIOQUÍMICOS, EXPRESSÃO GÊNICA, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana de Sá da et al. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems. Biochemical Engineering Journal, v. 161, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2020.107693. Acesso em: 07 nov. 2024.
APA
Silva, J. de S. da, Severino, P., Wodewotzky, T. I., Covas, D. T., Swiech, K., Marti, L. C., & Suazo, C. A. T. (2020). Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems. Biochemical Engineering Journal, 161, 1-9. doi:10.1016/j.bej.2020.107693
NLM
Silva J de S da, Severino P, Wodewotzky TI, Covas DT, Swiech K, Marti LC, Suazo CAT. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems [Internet]. Biochemical Engineering Journal. 2020 ; 161 1-9.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2020.107693
Vancouver
Silva J de S da, Severino P, Wodewotzky TI, Covas DT, Swiech K, Marti LC, Suazo CAT. Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems [Internet]. Biochemical Engineering Journal. 2020 ; 161 1-9.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.bej.2020.107693
Trabalho de evento-resumo periodico
Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC (2020)
Noronha, Nádia de Cássia ; Mizukami, Amanda ; Orellana, M. D.; Covas, Dimas Tadeu ; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FCFRP
Subjects: ANÓXIA, CÉLULAS ESTROMAIS, ADJUVANTES IMUNOLÓGICOS, HOMEOSTASE, DOENÇAS IMUNOLÓGICAS, DOENÇAS DEGENERATIVAS, SOBREVIVÊNCIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nádia de Cássia et al. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.705. Acesso em: 07 nov. 2024. , 2020
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Covas, D. T., Swiech, K., & Farias, K. C. R. M. de. (2020). Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.705
NLM
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705
Artigo de periodico
Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin (2020)
Silva, Luciano Costa e; Santos, Matheus Henrique; Heluy, Tárik Reis; Biaggio, Rafael Tagé; Ferreira, Alexander Rodrigo ; Lima, Jonathan Milhomens dos Santos; Haddad, Simone Kashima ; El Nemer, Wassim; El Hoss, Sara; Picanço-Castro, Virgínia ; Covas, Dimas Tadeu ; Swiech, Kamilla
Source: Engineering Reports. Unidades: FMRP, FCFRP
Subjects: ERITROPOIETINA, GLICOPROTEÍNAS, PROTEÍNAS RECOMBINANTES, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Luciano Costa e et al. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin. Engineering Reports, v. 2, n. 6, p. 1-16, 2020Tradução . . Disponível em: https://doi.org/10.1002/eng2.12172. Acesso em: 07 nov. 2024.
APA
Silva, L. C. e, Santos, M. H., Heluy, T. R., Biaggio, R. T., Ferreira, A. R., Lima, J. M. dos S., et al. (2020). Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin. Engineering Reports, 2( 6), 1-16. doi:10.1002/eng2.12172
NLM
Silva LC e, Santos MH, Heluy TR, Biaggio RT, Ferreira AR, Lima JM dos S, Haddad SK, El Nemer W, El Hoss S, Picanço-Castro V, Covas DT, Swiech K. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin [Internet]. Engineering Reports. 2020 ; 2( 6): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/eng2.12172
Vancouver
Silva LC e, Santos MH, Heluy TR, Biaggio RT, Ferreira AR, Lima JM dos S, Haddad SK, El Nemer W, El Hoss S, Picanço-Castro V, Covas DT, Swiech K. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin [Internet]. Engineering Reports. 2020 ; 2( 6): 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1002/eng2.12172
Artigo de periodico
Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
Picanço-Castro, Virgínia; Pereira, Cristiano Gonçalves; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Porto, Geciane Silveira
Source: Human Vaccines & Immunotherapeutics. Unidades: FMRP, FCFRP, FEARP
Subjects: PATENTE, TECNOLOGIA, CÉLULAS, TESTES LABORATORIAIS, INOVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 07 nov. 2024.
APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744
NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
Artigo de periodico
Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform (2020)
Moreira, Francisco; Mizukami, Amanda ; Souza, Lucas Eduardo Botelho de ; Cabral, Joaquim M. S.; Silva, Cláudia L. da; Covas, Dimas Tadeu ; Swiech, Kamilla
Source: Frontiers in Bioengineering and Biotechnology. Unidades: FMRP, FCFRP
Subjects: TECIDO ADIPOSO, CÉLULAS-TRONCO, MESODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Francisco et al. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Frontiers in Bioengineering and Biotechnology, v. 8, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.3389/fbioe.2020.00307. Acesso em: 07 nov. 2024.
APA
Moreira, F., Mizukami, A., Souza, L. E. B. de, Cabral, J. M. S., Silva, C. L. da, Covas, D. T., & Swiech, K. (2020). Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform. Frontiers in Bioengineering and Biotechnology, 8, 1-9. doi:10.3389/fbioe.2020.00307
NLM
Moreira F, Mizukami A, Souza LEB de, Cabral JMS, Silva CL da, Covas DT, Swiech K. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform [Internet]. Frontiers in Bioengineering and Biotechnology. 2020 ; 8 1-9.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fbioe.2020.00307
Vancouver
Moreira F, Mizukami A, Souza LEB de, Cabral JMS, Silva CL da, Covas DT, Swiech K. Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform [Internet]. Frontiers in Bioengineering and Biotechnology. 2020 ; 8 1-9.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fbioe.2020.00307
Artigo de periodico
DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes (2019)
Davanso, Mariana Rodrigues; Caliári Oliveira, Carolina; Couri, Carlos Eduardo Barra; Covas, Dimas Tadeu ; Leal, Ângela Merice de Oliveira; Voltarelli, Julio Cesar; Farias, Kelen Cristina Ribeiro Malmegrim de ; Yaochite, Juliana Navarro Ueda
Source: Inflammation. Unidades: FMRP, FCFRP
Subjects: PÂNCREAS, DIABETES MELLITUS, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVANSO, Mariana Rodrigues et al. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, v. 42, n. 2, p. 449-462, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10753-018-00954-3. Acesso em: 07 nov. 2024.
APA
Davanso, M. R., Caliári Oliveira, C., Couri, C. E. B., Covas, D. T., Leal, Â. M. de O., Voltarelli, J. C., et al. (2019). DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation, 42( 2), 449-462. doi:10.1007/s10753-018-00954-3
NLM
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s10753-018-00954-3
Vancouver
Davanso MR, Caliári Oliveira C, Couri CEB, Covas DT, Leal ÂM de O, Voltarelli JC, Farias KCRM de, Yaochite JNU. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes [Internet]. Inflammation. 2019 ; 42( 2): 449-462.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s10753-018-00954-3

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration